SNMMI: Incoming president talks meeting highlights, previews next year

Kate Madden Yee
Jun 2, 2026

Heather Jacene, MDHeather Jacene, MDAuntMinnie

In an interview at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, incoming society president Heather Jacene, MD, noted a key theme of the meeting -- namely an influx of research on new radiotracers for both disease identification and treatment -- and highlighted the society's plans for next year's meeting in Washington, D.C.

Check out AuntMinnie’s full coverage of SNMMI 2026 on our ShowCast. 

Latest in SNMMI 2026
Snmmi Thumb
SNMMI: Biomarkers predict I-131 response in obese thyroid cancer patients
June 2, 2026
RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.
SNMMI: Theranostic approach may treat PSMA-negative prostate cancer
June 2, 2026
A 68Ga-RCC78 PET scan (C) of a patient four years post-radical right nephrectomy. During follow-up, new nodules were detected in the left adrenal gland and kidney. CAIX-targeted scan clearly visualized metastatic lesions in the mediastinum, pancreas, adrenal gland, and kidney (SUVmax > 30), demonstrating the tracer's ability to maintain high tumor uptake despite significantly reduced abdominal background.
SNMMI: CAIX-targeted PET tracer detects clear cell renal cell carcinoma
June 1, 2026
Snmmi Thumb
SNMMI: Low-cost absorbents clear over 90% of Lu-177 from wastewater
June 1, 2026
Related Stories
(Left) F-18 GP1 PET/CT images from a 75-year-old woman show multiple blood clots in the deep veins of the left leg (from the thigh to the calf), as well as several clots in the right calf. Venous ultrasound confirms blood clots in left thigh, knee and calf veins. PET/CT also detects clots in both lungs, which are confirmed by contrast-enhanced CT image. (Right) 18F-GP1 PET/CT images from a 70-year-old woman show widespread blood clots throughout the body. In addition to clots in the deep veins of both legs and the arteries of both lungs (A), the scan also detected unexpected clots in several other areas, including blood vessels near the skull/head (B), spine (C), heart (D), and pelvis (E). Further evaluation revealed that the patient had antiphospholipid syndrome, an autoimmune condition that increases the risk of abnormal blood clot formation.
SNMMI 2026
SNMMI: PET tracer that detects deep vein thrombosis wins Image of the Year
Heather Jacene, MD, PhD
People in the News
BIDMC picks new molecular imaging, theranostics division chief
Jacene Heather Thumbnail
Molecular Imaging
SNMMI: Jacene named president-elect
Snmmi Thumb
SNMMI 2026
SNMMI: Biomarkers predict I-131 response in obese thyroid cancer patients
More in SNMMI 2026
SNMMI: Biomarkers predict I-131 response in obese thyroid cancer patients
By Kate Madden Yee
Metabolic status should be considered in post-therapy evaluation of obese differentiated thyroid cancer patients, researchers noted.
June 2, 2026
Snmmi Thumb
SNMMI: Theranostic approach may treat PSMA-negative prostate cancer
By Amerigo Allegretto
A theranostic approach could help improve PET imaging for neuroendocrine prostate cancer care.
June 2, 2026
RET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding peptide tracer [⁶⁸Ga]Ga-DOTA-RET-L7 in a neuroendocrine prostate cancer (NEPC) model, supporting highly specific, high-contrast detection.
SNMMI: CAIX-targeted PET tracer detects clear cell renal cell carcinoma
By Liz Carey
Researchers aim for "more precise molecular map" for kidney cancer.
June 1, 2026
A 68Ga-RCC78 PET scan (C) of a patient four years post-radical right nephrectomy. During follow-up, new nodules were detected in the left adrenal gland and kidney. CAIX-targeted scan clearly visualized metastatic lesions in the mediastinum, pancreas, adrenal gland, and kidney (SUVmax > 30), demonstrating the tracer's ability to maintain high tumor uptake despite significantly reduced abdominal background.
SNMMI: Low-cost absorbents clear over 90% of Lu-177 from wastewater
By Kate Madden Yee
An increase in the use of radionuclide therapy has added burden to wastewater management systems.
June 1, 2026
Snmmi Thumb
SNMMI honors Vasken Dilsizian with two distinctions at 2026 meeting
By AuntMinnie.com staff writers
Vasken Dilsizian, MD, has received the Wagner Lectureship and the Minoshima-Pappas Transformational Leadership Award.
June 1, 2026
Vasken Dilsizian, MD
SNMMI inducts six new fellows at 2026 annual meeting
By AuntMinnie.com staff writers
The SNMMI named six new fellows during its annual meeting in Los Angeles.
June 1, 2026
Snmmi Thumb
SNMMI names Richard Carson recipient of 2026 Aebersold Award
By AuntMinnie.com staff writers
The SNMMI has awarded the Aebersold Award to Richard Carson, PhD, from Yale University.
June 1, 2026
Trophy Award 400
SNMMI: PET tracer that detects deep vein thrombosis wins Image of the Year
By Will Morton
F-18 GP1 is derived from elarofiban and selectively binds to glycoprotein IIb/IIIa receptors on activated platelets.
June 1, 2026
(Left) F-18 GP1 PET/CT images from a 75-year-old woman show multiple blood clots in the deep veins of the left leg (from the thigh to the calf), as well as several clots in the right calf. Venous ultrasound confirms blood clots in left thigh, knee and calf veins. PET/CT also detects clots in both lungs, which are confirmed by contrast-enhanced CT image. (Right) 18F-GP1 PET/CT images from a 70-year-old woman show widespread blood clots throughout the body. In addition to clots in the deep veins of both legs and the arteries of both lungs (A), the scan also detected unexpected clots in several other areas, including blood vessels near the skull/head (B), spine (C), heart (D), and pelvis (E). Further evaluation revealed that the patient had antiphospholipid syndrome, an autoimmune condition that increases the risk of abnormal blood clot formation.
SNMMI: Novel radiotracer effectively images overactive adrenal glands
By Liz Carey
University of Michigan researchers report on first-in-human study of SOAT1-targeted nevanimibe C-11.
June 1, 2026
Static PET-CT image of patient with hypercortisolism taken at 60 minutes post-injection.
SNMMI: Mouaz Al-Mallah discusses cardiac PET
By Will Morton
In this interview, Mouaz Al-Mallah, MD, discusses cardiac PET imaging, including new efforts to create more access for patients and the impact of new radiotracers.
June 1, 2026
Mouaz Al Mallah Thumb1
SNMMI: Point-of-care PET system may guide interventional procedures
By Amerigo Allegretto
A portable, point-of-care PET system showed success in imaging organs and may be helpful in interventional guidance.
June 1, 2026
(a) Benchtop portable POC-PET prototype system. (b) Phantom imaging experiment setup. (c) Comparison of conventional full-data MLEM reconstruction with incremental OSEM reconstruction.
SNMMI: Brain-dedicated PET scanner cuts claustrophobia, boosts comfort
By Kate Madden Yee
The findings "support the use of brain-dedicated PET scanners as a patient-centered alternative," researchers wrote.
June 1, 2026
Snmmi Thumb
Page 1 of 3
Next Page